Welcome to the BioEngagement blog

Karen Jones

As I go about my daily work, I come across issues, interesting anecdotes, mistakes, recoveries, and all the other things in between that make my job so interesting and varied. Many of these observations resound with more than the odd company operating in biotech, lifescience and beyond, and I thought that keeping a record of them might prove useful to many others who slog away, trying to make successful businesses in this risky, interesting and challenging environment.

If you would like to contribute an article to this blog, please email karen.jones@bioengagement.com. I am always on the lookout for new perspectives from people who don't necessarily think like me.

If you like what you read and think I might be able to help your business, please email me or give me a call on +44(0)1617 712185.


Cardiotoxicity Testing Grows Up?

Drug-related cardiotoxicity causes 45% of drug withdrawals. Yet no FDA guidelines or standard preclinical tests, or clinical biomarkers exist. What’s in store for cardiotoxicity testing in drug discovery and development?

Read more ...

Nicely Done: Cellzome

logo Nicely Done: Cellzome
This morning I came across Cellzome’s website and on further exploration I think it’s an excellent example of a technology platform company that’s got it right. You don’t see many of these, and I think it serves as a good role model to learn from.

Firstly, The Thing That Attracted Me: Presentation

Cellzome’s website is small, simple and a similar website would be inexpensive to develop (around £7K including content). Its simplicity and clarity is what makes it special. No heavy word-ridden content; just clear and simple messages:

  • a small molecule drug discovery technology platform using chemoproteomics for epigenetic and

Read more ...

Stuck? Get Client Feedback.

thumbs up down 300x201 Stuck? Get Client Feedback.
Last week I got a call from an old friend and ex-colleague who bemoaned about how the marketing tactics at his very large life science technology company had pretty much reduced to a handle-turning exercise that was no longer working. Open rates on their emails had fallen to an all-time low, social media efforts were “unproven”, leads coming in from phone and website had dropped off.

When you look at a problem like this, it’s tempting to respond by changing the tactics, refreshing the branding and content, and give the marketing campaigns a “reboot”. Try a webinar series, a workshop, …

Related Posts Plugin for WordPress, Blogger...

Read more ...

What They Are Saying…

“Karen Jones, managing director of Bioengagement, has a very strong expertise in developing marketing campaigns/strategies for life science products and services. With her support we managed to reach our ambitious targets, engaged work with 15 new clients in less than 6 months and generated over 30 new leads."
Frederic Girard, CEO Spinnovation-Analytical.

Read more testimonials...

BioEngagement on Twitter

"Interesting read: Foundings Matter: Thiel’s Law Applied To Biotech http://t.co/ruG4cZpKyq"
over a year ago
"Here's us at #eshg2013. Mini lab with working Ion PGM sequencer in back. So much excitement and interest http://t.co/E2mSirhwMM"
over a year ago
"Interesting read: Debunking Myths About Biotech Venture Capital http://t.co/3wYD3fII6V"
over a year ago

© 2015 Bioengagement. Powered by Wordpress, tailored by Weblucent.